115) appear to be diagnostic of WAS. To determine if the membrane glycoprotein abnormalities have morphological consequences, normal and WAS peripheral blood lymphocytes (PBL) and thymocytes were fixed in 1.2% glutaraldehyde and examined by scanning electron microscopy (SEM). Using a 1 to 4 grading scale based upon the character of the lymphocyte surface projections (4 = villus projections on > 75% of lymphocyte surface area; 3 = villus projections on < 75% of surface area; 2 = ridge projections; 1 = no projections), normal PBL had an average score of 3.60k.lO(SE); thymocytes, 2.00k.02; WAS PBL, 2.76k.07 (n = 14).
The decreased score of WAS lymphocytes was due to a decrease in the percentage of cells with villus projections and an increase in the percentage of cells with ridge or no projections. SEM has been used to confirm the diagnosis of WAS on the cord blood lymphocytes of one patient. WAS represents the first lymphoid immunodeficiency in which morphological abnormalities have been identified that can be used for diagnostic purposes.
RESTORATION OF IN VITRO FUNCTION OF ADENOSINE
Morton J Cowan and Arthur J Ammann, University of California, School of Medicine, Department of Pediatrics, San Francisco, CA.
We evaluated the effects of recombinant DNA IL-2, a T-cell lymphokine which is essential for normal immune function on the responses to mitogen and alloantigen of peripheral blood mononuclear cells (PBMC) from 3 ADA deficient patients. There was significant enhancement by IL-2 of mitogenic responses to phytohemagglutinin (PHA) , pokeweed mitogen (PWM) and alloantigen (MLR) in all 3 patients. Patients with ADA positive severe combined immunodeficiencv disease showed no resnonses to IL-2: The antibody 3F8, an IgG3 murine Mab we have developed to human NB,could specifically target iodine 131 to human NB xenoxenograft with tumor to non tumor ratios of 10-100 and a relative radiation dose deposition to normal organs of 1 to 20% of that to the tumor. We therefore studied its efficacy in tumor therapy. Nude mice with actively growing sc human NB (1-2 gm size) were injected with 0.125 to 1 mCi iodine carried on 100 to 200 ug Mab 3F8. Tumor size was followed by direct measurement. Actual tumor weight and measured size showed good correlation (r= 0.985).
Tumor radioactivity over time was calculated from the gamma images using a known 131-1 standard. All the tumors had effective half lives averaging 48 hours. Radiation dose to individual tumors were calculated. Tumor shrinkage only occurred with 131-1 3F8 Mab, but not with nonradioactive 3F8 or radiolabeled irrelevant Mab. While control mice tumor enlarged by 10 fold, treated tumor showed 95% shrinkage by 12 days. Both the rate of shrinkage and duration of response were dose dependent. Only those tumors that received 4700 rads were completely ablated without recurrence. There were no toxicities except reversible weight loss. Thus, human NB xenografts could be effectively eradicated using iodine 131 labeled Mab 3F8 with tolerable toxicities. ~arious~forms of cellular cytotoxicity have been noted by us and others to be decreased in newborn whole mononuclear cells (WMC) as compared with adult WMC. Diminished cord spontaneous natural killer (NK) cell activity against K562 targets has been observed. However, after incubation for 5-7 days with purified recombinant interleukin-2 (IL-2) cord WMC cytotoxicity against K562 cells increased from 16 + 2% (SEM) to 74 + 5% (n=9).
Killing of Raji cells increased from 7 + 1% to-38 + 4% ( n . 9 ) .
Similarly activated adult WMC also increased thei r-kil ling against K562 from 31 5 4% to 68 5 7% and against Raji cells from 7 + 1% to 40 + 7% (n=10). Dose-dependent responses were observed wiih the optiiiial IL-2 concentration at 50-100 unitslcc. Increased cytotoxicity was also observed against other cell targets (Molt 4F and EL-4). Cold target inhibition of Molt and Raji killing was equally inhibited in adult and cord lymphokineactivated killer cells (LAK) by K562, Molt or Raji cells. However, cold target inhibition of cord LAK activity against K562 was less than adult LAK, suggesting less specificity and more potent cytotoxic potential. Unlabelled K562 cells decreased cytotoxicity by 44 + 5% for adult LAK (n=7) The Chromosomal Break Syndromes: Ataxia Telangiectasia, Fanconi's Anemia, and Bloom's Syndrome are associated with growth failure, microcephaly, neurologic abnormalities, immunodeficiency, failure of secondary sexual characteristics and an increased incidence of malignancy. The relationship between these features is unknown. We recently evaluated a 21 year old female with more severe chromosomal breakage, immunodeficiency and growth failure than in any of the above disorders. It is of note that she has not yet developed a malignancy. Growth failure was apparent in the first year of l if.e and lymphopenia and hypogammaglobulinemia at age 6. At 18 years of age, her weight was 22.6kg (50th% for 7 years) height was 129 cm (50th% for 8 years) OFC was 42 cm (50th% for 6 months). The peripheral blood contained 400-900 lymphocytes/mm3 with 32% TI 1 cells, 17% TI, and 21% Tg cells. The proliferative response to the mitogens PHA, PWM and ConA was less than 5% of control. There were 0.2% surface IgM bearing cel Is (nl 4-Is%), and serum lgG was 185 mg/dl , IgM 7 mg/dl , IgA <5 mg/dl . In lymphocyte cultures stimulated with mitogens for T cells (pHA/TPA) or B cells (EBV), nearly half the metaphases examined had one or more chromosome breaks or rearrangements, but there was no evidence of a cytogenetically-abnormal clone. These findings suggest that factors other than the severity of the imnunodeficiency or the high incidence of chromosomal damage contribute to the occurrence of malignancy in the Chromosomal Break Syndromes.
